| Ongoing clinical trials for the management of the COVID-19 pandemic MP Lythgoe, P Middleton Trends in pharmacological sciences 41 (6), 363-382, 2020 | 433 | 2020 |
| Metformin selectively targets redox control of complex I energy transduction AR Cameron, L Logie, K Patel, S Erhardt, S Bacon, P Middleton, J Harthill, ... Redox Biology 14, 187-197, 2018 | 145 | 2018 |
| Clinical characteristics and predictors of outcomes of hospitalized patients with COVID-19 in a multi-ethnic London NHS Trust: a retrospective cohort study PN Perez-Guzman, A Daunt, S Mukherjee, P Crook, R Forlano, MD Kont, ... Clin Infect Dis 7, ciaa1091, 2020 | 110* | 2020 |
| In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19 R Forlano, BH Mullish, SK Mukherjee, R Nathwani, C Harlow, P Crook, ... PLoS One 15 (10), e0240400, 2020 | 65 | 2020 |
| The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin‐α JG Orr, CJ Currie, E Berni, A Goel, KJ Moriarty, A Sinha, F Gordon, ... Liver International 36 (9), 1295-1303, 2016 | 53 | 2016 |
| Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulation P Middleton, N Vergis Therapeutic Advances in Gastroenterology 14, 17562848211031394, 2021 | 51 | 2021 |
| Comparison of COVID-19 vaccine approvals at the US Food and Drug administration, European Medicines agency, and health Canada MP Lythgoe, P Middleton JAMA Network Open 4 (6), e2114531-e2114531, 2021 | 33 | 2021 |
| Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studies P Middleton, C Hsu, MP Lythgoe BMJ open gastroenterology 8 (1), e000739, 2021 | 30 | 2021 |
| Dysfunctional neutrophil effector organelle mobilization and microbicidal protein release in alcohol-related cirrhosis TH Tranah, GKM Vijay, JM Ryan, RD Abeles, PK Middleton, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 313 (3 …, 2017 | 19 | 2017 |
| Characteristics and outcomes of clinically diagnosed RT-PCR swab negative COVID-19: a retrospective cohort study P Middleton, PN Perez-Guzman, A Cheng, N Kumar, MD Kont, A Daunt, ... Scientific Reports 11 (1), 2455, 2021 | 16 | 2021 |
| Impact of therapeutic drug level monitoring on outcomes of patients with Crohn’s disease treated with Infliximab: real world data from a retrospective single centre cohort study N Kamperidis, P Middleton, T Tyrrell, I Stasinos, N Arebi Frontline gastroenterology 10 (4), 330-336, 2019 | 15 | 2019 |
| Il-1beta signal inhibition in acute alcoholic hepatitis: a multicentre, randomised, double-blind, placebo-controlled phase 2 trial of canakinumab therapy (ISAIAH) N Vergis, VC Patel, K Bogdanowicz, J Czyzewska-Khan, R Keshinro, ... Journal of Hepatology 77, S34-S35, 2022 | 9 | 2022 |
| Implementation of an intervention bundle leads to quality improvement in ulcerative colitis endoscopy reporting R Kader, RJ Dart, G Sebepos‐Rogers, E Shakweh, P Middleton, ... GastroHep 2 (6), 309-317, 2020 | 3 | 2020 |
| Teaching wilderness and outdoor medicine in a city P Lockwood, P Middleton The Clinical Teacher 10 (6), 389-393, 2013 | 2 | 2013 |
| P148 An intervention bundle leads to quality improvement in endoscopic reporting of ulcerative colitis E Shakweh, P Middleton, O Ahmad, R Dart, J McGuire, R Kader, ... Gut 70 (Suppl 1), A119-A120, 2021 | 1 | 2021 |
| Thalidomide therapy in recurrent gastrointestinal bleeding due to angiodysplasia CC Shekar, MH Miller, E Rooke, P Middleton, JF Dillon Journal of Hepatology 60 (1 (Supplement)), S390, 2014 | 1 | 2014 |
| P204 Mitochondrial dysfunction may explain innate immunoparesis and susceptibility to infection of patients with alcoholic hepatitis P Middleton, M Thursz, N Vergis Gut 70 (Suppl 1), A148-A149, 2021 | | 2021 |
| Characteristics and outcomes of clinically diagnosed RT-PCR swab negative COVID-19: a retrospective cohort study (preprint) P Middleton, PN Perez-Guzman, A Cheng, N Kumar, M Kont, A Daunt, ... | | 2020 |
| Dysfunctional neutrophil effector organelle mobilization and microbicidal protein release in alcohol-related cirrhosis (vol 313, pg G203, 2017) TH Tranah, MGK Vijay, JM Ryan, RD Abeles, PK Middleton, ... AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY 314 (3 …, 2018 | | 2018 |
| P569 Outcomes of IBD patients treated with infliximab: The impact of therapeutic drug monitoring in real-life clinical practice N Kamperidis, P Middleton, T Tyrrell, I Stasinos, N Arebi Journal of Crohn's and Colitis 12 (supplement_1), S394-S394, 2018 | | 2018 |
